Compile Data Set for Download or QSAR
maximum 50k data
Found 52 Enz. Inhib. hit(s) with all data for entry = 50000813
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010161(CHEMBL2370397 | [16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  58nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010161(CHEMBL2370397 | [16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  62nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50040751(CHEMBL351938 | [(4S,7S,13R,16S)-16-Acetylamino-4-c...)
Affinity DataKi:  720nMAssay Description:Inhibition of 125[I] Fibrinogen binding to isolated purified human fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010176(CHEMBL107009 | [(4S,7R,13R,16S)-16-Acetylamino-4-c...)
Affinity DataKi:  780nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50003326(3-[2-(2-Acetylamino-5-guanidino-pentanoylamino)-ac...)
Affinity DataKi:  4.20E+3nMAssay Description:Inhibition of 125[I] Fibrinogen binding to isolated purified human fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010187(CHEMBL320288 | [19-Acetylamino-4-carbamoyl-16-(3-g...)
Affinity DataKi:  5.30E+3nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010184(3-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataKi: <1.00E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010167(1N-[1-[5-amino-1-formyl-(1S)-pentylcarbamoyl]-(1S)...)
Affinity DataKi:  1.45E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50003326(3-[2-(2-Acetylamino-5-guanidino-pentanoylamino)-ac...)
Affinity DataKi:  6.20E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010161(CHEMBL2370397 | [16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataIC50:  355nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010193(CHEMBL2370407 | [16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataIC50:  370nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50040751(CHEMBL351938 | [(4S,7S,13R,16S)-16-Acetylamino-4-c...)
Affinity DataIC50:  4.10E+3nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50421884(CHEMBL2110309)
Affinity DataIC50:  4.12E+3nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010171(CHEMBL2370393 | [16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataIC50:  7.97E+3nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010179(1N-[1-formyl-(1S)-ethylcarbamoylmethylcarbamoylmet...)
Affinity DataIC50:  9.60E+3nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010177(CHEMBL2370394 | [19-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataIC50:  1.14E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010176(CHEMBL107009 | [(4S,7R,13R,16S)-16-Acetylamino-4-c...)
Affinity DataIC50:  1.62E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010187(CHEMBL320288 | [19-Acetylamino-4-carbamoyl-16-(3-g...)
Affinity DataIC50:  3.27E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010189(3-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50:  4.05E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010175(CHEMBL107169 | [19-Acetylamino-4-carbamoyl-13-(3-g...)
Affinity DataIC50:  5.20E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010166(CHEMBL2370399 | [16-Acetylamino-13-(4-amino-butyl)...)
Affinity DataIC50:  5.53E+4nMAssay Description:Inhibition of 125[I] Fibrinogen binding to isolated purified human fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010184(3-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50:  5.55E+4nMAssay Description:Inhibition of human washed platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50003326(3-[2-(2-Acetylamino-5-guanidino-pentanoylamino)-ac...)
Affinity DataIC50:  6.72E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010168(3-[5-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50:  6.82E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010183(CHEMBL353203 | [16-Acetylamino-4-carbamoyl-13-(3-g...)
Affinity DataIC50:  7.34E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010182(3-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50:  7.59E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010178(CHEMBL2370398 | [4-Acetyl-16-acetylamino-13-(2-car...)
Affinity DataIC50:  8.20E+4nMAssay Description:Inhibition of 125[I] Fibrinogen binding to isolated purified human fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50003326(3-[2-(2-Acetylamino-5-guanidino-pentanoylamino)-ac...)
Affinity DataIC50:  9.13E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010173(4-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50:  9.70E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010192(3-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50:  1.02E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010188(3-[4-amino(imino)methylamino-1-[4-amino(imino)meth...)
Affinity DataIC50:  1.13E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010174(3-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50:  1.38E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010160(3-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50:  1.38E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010190(1N-[1-carbamoyl-2-hydroxy-(1S)-ethyl]-2-[4-amino(i...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010170(4-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010167(1N-[1-[5-amino-1-formyl-(1S)-pentylcarbamoyl]-(1S)...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010162(CHEMBL2370401 | [16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataIC50:  2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010185(16-Acetylamino-7-carbamoylmethyl-13-(3-guanidino-p...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50421885(CHEMBL2111672)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010194(16-(2-Acetylamino-6-amino-hexanoylamino)-7-carboxy...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010156(3-[1-carbamoyl-2-hydroxy-(1S)-ethylcarbamoyl]-3-[2...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010169(3-[5-amino-1-methylcarboxamido-(1S)-pentylcarboxam...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010163(3-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of 125[I] Fibrinogen binding to isolated purified human fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010172(3-[1-carbamoyl-2-hydroxy-(1S)-ethylcarbamoyl]-3-[2...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010180(3-[1-[4-amino(imino)methylamino-1-methylcarboxamid...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010165(3-[1-[5-amino(imino)methylamino-2-methylcarboxamid...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010186(3-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010158(3-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010191(4-[5-amino-1-methylcarboxamido-(1S)-pentylcarboxam...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of human washed platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010164(2-[4-amino(imino)methylamino-1-methylcarboxamido-(...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of thrombin-stimulated platelet aggregation in dogsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: